Cargando…

What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary

Detalles Bibliográficos
Autor principal: Sen, Ekin Ilke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438519/
https://www.ncbi.nlm.nih.gov/pubmed/36046985
_version_ 1784781842339069952
author Sen, Ekin Ilke
author_facet Sen, Ekin Ilke
author_sort Sen, Ekin Ilke
collection PubMed
description
format Online
Article
Text
id pubmed-9438519
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Musculoskeletal and Neuronal Interactions
record_format MEDLINE/PubMed
spelling pubmed-94385192022-09-16 What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary Sen, Ekin Ilke J Musculoskelet Neuronal Interact Cochrane Corner International Society of Musculoskeletal and Neuronal Interactions 2022 /pmc/articles/PMC9438519/ /pubmed/36046985 Text en Copyright: © Journal of Musculoskeletal and Neuronal Interactions https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cochrane Corner
Sen, Ekin Ilke
What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary
title What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary
title_full What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary
title_fullStr What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary
title_full_unstemmed What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary
title_short What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary
title_sort what are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - a cochrane review summary with commentary
topic Cochrane Corner
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438519/
https://www.ncbi.nlm.nih.gov/pubmed/36046985
work_keys_str_mv AT senekinilke whataretheeffectsofsystemictherapiesforthepreventionandtreatmentofaromataseinhibitorinducedmusculoskeletalsymptomsinearlybreastcanceracochranereviewsummarywithcommentary